AU Stock MarketDetailed Quotes

ACL Australian Clinical Labs Ltd

Watchlist
  • 3.460
  • +0.040+1.17%
20min DelayNot Open Dec 12 16:00 AET
694.61MMarket Cap28.83P/E (Static)

Australian Clinical Labs Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Australian Clinical Labs Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 26, 20252025/H2-- / 378.400M--
Feb 27, 20252025/H1-- / 354.600M--
Aug 29, 20242024/H2358.552M / 350.740M--
Feb 28, 20242024/H1337.816M / 340.650M--
Aug 22, 20232023/H2336.760M / 351.570M--
DatePeriodRevenue/EstimateEarnings Call
Aug 26, 20252025/H2-- / 378.400M--
Feb 27, 20252025/H1-- / 354.600M--
Aug 29, 20242024/H2358.552M / 350.740M--
Feb 28, 20242024/H1337.816M / 340.650M--
Aug 22, 20232023/H2336.760M / 351.570M--

Unlock Free Earnings Estimates

Australian Clinical Labs Ltd Earnings Reports

  • Australian Clinical Labs Ltd: AGM addresses

    Oct 24 18:14 ET

  • Australian Clinical Labs Ltd: 2024 Annual Report

    Sep 22 20:00 ET

  • Australian Clinical Labs Ltd: FY24 financial results investor presentation

    Aug 28 18:30 ET

  • Australian Clinical Labs Ltd: Appendix 4E and FY24 financial statements

    Aug 28 18:29 ET

    • Read more

    Trending AU Stocks
    ASX High Dividend ASX High Dividend
    Symbol Mini Chart % Chg
    Fortescue Ltd
    FMG
    +0.60%
    Rio Tinto Ltd
    RIO
    +0.27%
    ANZ Group Holdings Ltd
    ANZ
    +0.10%
    National Australia Bank Ltd
    NAB
    +0.08%
    CommBank
    CBA
    0.00%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Nov 15, 2024

    Buy

    • Strong Buy

      42.86%

    • Buy

      14.29%

    • Hold

      42.86%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data